All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @usweekly on TikTok · 45s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @usweekly's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00I am not a liar.
  2. 0:01I have never gone under the knife to get anything done.
  3. 0:04There's been no nips tucks, whatever the hell,
  4. 0:07no is epic, nothing like that.
  5. 0:09I know that.
  6. 0:10Like I know that.
  7. 0:12But to be called a liar, to have people feel like
  8. 0:16I'm being, that they're being gassed lit or gassed lighted,
  9. 0:20it obviously doesn't feel good.
  10. 0:21But I also know my truth.
  11. 0:22I believe people are just so quick to solve
  12. 0:25whatever they think the issue is, right?
  13. 0:28Like what happened to the good old school healthy way?
  14. 0:31Why is that just not possible?
  15. 0:32Why is it not part of your many options for me?
  16. 0:34It's just like, it's just different for people.
  17. 0:36They're like, where is we missed the old Cheryl?
  18. 0:39Oh well, you know, like this is who I am today.
  19. 0:41Whether you want to label me old or new, it's irrelevant.

Cheryl Burke, Ozempic rumors, and what GLP-1 stigma actually costs

Us Weekly

TikTok creator

90.4K viewsWatch on TikTok

Quick answer

Cheryl Burke denied using semaglutide (branded as Ozempic) or undergoing cosmetic surgery, attributing her body changes to lifestyle methods and framing her sobriety as part of that process. Alcohol cessation is associated with reduced caloric intake and body composition changes, providing a plausible biological mechanism for weight loss without pharmacological intervention, though individual outcomes vary significantly. GLP-1 receptor agonists remain FDA-approved, evidence-backed options for weight management, and their use carries no ethical or medical stigma that would make a denial necessary.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksCompounded SemaglutideProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Compounded Semaglutide access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 7 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Cheryl Burke, Ozempic rumors, and what GLP-1 stigma actually costs, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

Compounded Semaglutide should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Claim path

Keep researching this semaglutide video claims cluster

Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Cheryl Burke, Ozempic rumors, and what GLP-1 stigma actually costs" from Us Weekly. We read the clip as a GLP-1 social video fact-checks claim about Compounded Semaglutide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Cheryl Burke denied using semaglutide (branded as Ozempic) or undergoing cosmetic surgery, attributing her body changes to lifestyle methods and framing her sobriety as part of that process.

The reason this review is not generic is the source wording and the canonical claim label "glp1 cheryl burke says the ozempic and surgery allegations hurt h." In this clip, the useful excerpt is: "I am not a liar." That wording changes the review because it points to Compounded Semaglutide safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Compounded Semaglutide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Alcohol cessation alone can reduce daily caloric intake by 200-400 calories and shift body fat distribution, according to a 2020 review by Traversy and Chaput in Current Obesity Reports.
People who land here are usually trying to understand whether the Compounded Semaglutide claim is evidence-backed, safe, and relevant to their own situation.
The strongest next step is to compare the claim with FormBlends' Compounded Semaglutide guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Cheryl Burke denied using semaglutide (branded as Ozempic) or undergoing cosmetic surgery, attributing her body changes to lifestyle methods and framing her sobriety as part of that process.

FormBlends verdict

Compounded Semaglutide safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Cheryl Burke denied using semaglutide (branded as Ozempic) or undergoing cosmetic surgery, attributing her body changes to lifestyle methods and framing her sobriety as part of that process. Alcohol cessation is associated with reduced caloric intake and body composition changes, providing a plausible biological mechanism for weight loss without pharmacological intervention, though individual outcomes vary significantly. GLP-1 receptor agonists remain FDA-approved, evidence-backed options for weight management, and their use carries no ethical or medical stigma that would make a denial necessary.
  • The STEP 1 trial (Wilding et al., 2021, NEJM) showed semaglutide 2.4mg produced an average 14.9% body weight loss over 68 weeks, making it one of the most effective non-surgical weight loss interventions available.
  • Alcohol cessation alone can reduce daily caloric intake by 200-400 calories and shift body fat distribution, according to a 2020 review by Traversy and Chaput in Current Obesity Reports.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.

Review Compounded Semaglutide

What You'll Learn

  • The STEP 1 trial (Wilding et al., 2021, NEJM) showed semaglutide 2.4mg produced an average 14.9% body weight loss over 68 weeks, making it one of the most effective non-surgical weight loss interventions available.
  • Alcohol cessation alone can reduce daily caloric intake by 200-400 calories and shift body fat distribution, according to a 2020 review by Traversy and Chaput in Current Obesity Reports.
  • Intensive lifestyle intervention without medication produces average weight loss of 5-10% of body weight in clinical trials, and higher in individuals with strong adherence, per Wadden et al. (2021, NEJM).
  • GLP-1 medications like semaglutide and tirzepatide are FDA-approved treatments for obesity and type 2 diabetes. Using them is a medical decision, not a moral failing, and public stigma around their use is not clinically justified.
  • The implied premise in celebrity body speculation, that dramatic weight change requires drugs or surgery, ignores documented individual variation in response to lifestyle change, sobriety, and metabolic factors.
  • Stigma associated with weight loss methods, whether surgical, pharmacological, or behavioral, has no basis in clinical evidence and can cause measurable psychological harm, including risk to sobriety in people with alcohol use disorder.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @usweekly actually say?

Cheryl Burke, speaking in an exclusive interview clip posted by @usweekly, flatly denied two specific allegations: that she had cosmetic surgery and that she used semaglutide (Ozempic). Her exact words: "I have never gone under the knife" and "no Ozempic, nothing like that." She also pushed back on being called a liar and framed her weight loss as the result of conventional, lifestyle-based methods.

This is a celebrity denying medical allegations, not a health educator making clinical claims. That framing matters. The video itself does not teach viewers anything about GLP-1 drugs, surgery risks, or weight loss science. What it does do, especially with 90,000+ views, is feed a broader cultural narrative that dramatic body changes can only be explained by surgery or Ozempic. That assumption deserves scrutiny regardless of whether Burke's denial is true.

Does the science back this up?

Her core implicit argument, that meaningful weight loss through lifestyle changes alone is possible and underappreciated, is actually well-supported by evidence. Reviewers consistently overestimate the role of drugs and surgery in celebrity body transformations, partly because GLP-1 medications have become so visible in public conversation.

Significant weight loss without pharmacological or surgical intervention is documented. A 2021 paper by Wadden et al. in the New England Journal of Medicine found that intensive lifestyle intervention alone produced an average 5-10% body weight reduction in clinical trials. For some individuals with high adherence, the results are more dramatic. Sobriety from alcohol, which Burke has discussed publicly, is itself associated with meaningful changes in body composition. A 2020 review by Traversy and Chaput in Current Obesity Reports noted that alcohol cessation can reduce caloric intake by hundreds of calories per day and shift fat distribution. Burke has been public about her sobriety journey, which gives her "healthy old school way" claim at least a plausible biological grounding, even if we can't verify it from a TikTok clip alone.

What did they get wrong (or right)?

Burke got the tone right even if the content is unverifiable. She didn't make false clinical claims. She didn't promote Ozempic or discourage its use irresponsibly. She said "it's just different for people," which is a reasonable acknowledgment that weight loss paths vary.

What she got slightly muddled is the gaslighting framing. Gaslighting is a specific psychological term for deliberate manipulation. Public speculation about someone's body is intrusive and often sexist, but it isn't gaslighting in the clinical sense. That's a minor complaint about word choice, not a substantive error.

The bigger issue isn't what Burke said. It's the implied premise her audience may take away: that asking whether someone used Ozempic is inherently accusatory or shameful. GLP-1 drugs are FDA-approved, effective, and used by millions of people managing obesity or type 2 diabetes. The stigma baked into allegations like these, where using a legitimate medication is treated as something to deny rather than simply discuss, is worth naming directly.

What should you actually know?

GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) produce real, clinically significant weight loss. The STEP 1 trial (Wilding et al., 2021, NEJM) showed an average 14.9% body weight reduction with semaglutide 2.4mg over 68 weeks. These are not cheating. They are medicines.

But lifestyle change also works, particularly when alcohol is removed from the equation. The body's response to caloric reduction, increased movement, and sobriety can be dramatic enough to invite exactly the kind of public speculation Burke is dealing with. Neither explanation should be shameful, which is the real takeaway here.

If you are considering a GLP-1 medication for weight management, that decision belongs in a clinical conversation with a licensed provider, not in the comments section of a celebrity interview. What someone else did or did not take has no bearing on whether it is appropriate for you.

The bottom line on this video

This is a personal denial clip, not a health video, and judging it purely on clinical accuracy misses the point. Burke makes no false medical claims. Her implicit argument that lifestyle change produces real results is supported by evidence. The more important lesson is what the public reaction to her body reveals: we have collectively medicalized dramatic transformation to the point where people feel accused when they lose weight, and defensive when they deny taking medication that, frankly, they would have every right to take.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Us Weekly · TikTok creator

90.4K views on this video

Cheryl Burke says the Ozempic and surgery allegations hurt her and even threatened her sobriety. “I’m not a liar,” she says in our exclusive interview — read more at the link in our bio.

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about the step 1 trial (wilding et al., 2021, nejm) showed?

The STEP 1 trial (Wilding et al., 2021, NEJM) showed semaglutide 2.4mg produced an average 14.9% body weight loss over 68 weeks, making it one of the most effective non-surgical weight loss interventions available.

What does the video say about alcohol cessation alone can reduce daily caloric intake by 200-400?

Alcohol cessation alone can reduce daily caloric intake by 200-400 calories and shift body fat distribution, according to a 2020 review by Traversy and Chaput in Current Obesity Reports.

What does the video say about intensive lifestyle intervention without medication produces average weight loss of?

Intensive lifestyle intervention without medication produces average weight loss of 5-10% of body weight in clinical trials, and higher in individuals with strong adherence, per Wadden et al. (2021, NEJM).

What does the video say about glp-1 medications like semaglutide?

GLP-1 medications like semaglutide and tirzepatide are FDA-approved treatments for obesity and type 2 diabetes. Using them is a medical decision, not a moral failing, and public stigma around their use is not clinically justified.

What does the video say about the implied premise in celebrity body speculation,?

The implied premise in celebrity body speculation, that dramatic weight change requires drugs or surgery, ignores documented individual variation in response to lifestyle change, sobriety, and metabolic factors.

What does the video say about stigma associated with weight loss methods, whether surgical, pharmacological,?

Stigma associated with weight loss methods, whether surgical, pharmacological, or behavioral, has no basis in clinical evidence and can cause measurable psychological harm, including risk to sobriety in people with alcohol use disorder.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Us Weekly, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.